MoonLake Immunotherapeutics (MLTX) Research & Development (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded Research & Development of $50.22 million in Q2 2026, up 0.9% from $49.76 million a year earlier but down 7.9% from the prior quarter.
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Research & Development (2021 - 2026) Analysis & Trends
On a TTM basis, MoonLake Immunotherapeutics' Research & Development came in at $221.38 million as of Jun 30, 2026, up 36.4% year-over-year; for FY2025, it came in at $202.86 million, up 79.9% from FY2024.
- Annual Research & Development has a four-year compound annual growth rate of 54.6% (FY2021 to FY2025).
- Across earlier years, Research & Development came in at $112.77 million in FY2024 (+254.6%), $31.8 million in FY2023 (-24.4%), $42.05 million in FY2022 (+18.3%) and $35.53 million in FY2021.
- Quarterly Research & Development has ranged from $669,528 in Q3 2021 to $60.64 million in Q3 2025 over the past five years.
- On a year-over-year basis, Research & Development has increased for ten consecutive quarters, with growth averaging 152.4% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 398.4% in Q4 2024, against a decline of 61.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $54.52 million (Q1 2026), $56.01 million (Q4 2025) and $60.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | MoonLake Immunotherapeutics | 983.83 Mn | -685.56 Mn | - | 50.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.22 Mn |
| Mar 31, 2026 | 54.52 Mn |
| Dec 31, 2025 | 56.01 Mn |
| Sep 30, 2025 | 60.64 Mn |
| Jun 30, 2025 | 49.76 Mn |
| Mar 31, 2025 | 36.46 Mn |
| Dec 31, 2024 | 40.36 Mn |
| Sep 30, 2024 | 35.74 Mn |
| Jun 30, 2024 | 23.66 Mn |
| Mar 31, 2024 | 13.01 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 7.59 Mn |
| Jun 30, 2023 | 8.70 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 11.37 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 669,528.00 |
API Access
MoonLake Immunotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MLTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MLTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MLTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();